Laura Martin
Family Medicine · Liverpool, NYNPI 1558322339
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (44.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Indivior Inc. accounts for 63.4% of it on its own, with 35 other manufacturers making up the rest. Reporting peaked in 2019 at $12,823 and has fallen 99.7% since, to $40 in 2023. Among family medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 555 payments — averaging $33.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Indivior Inc.$12K
- Amgen$659
- AbbVie$622
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$555
- Boehringer Ingelheim$540
- GSK$454
- plus $4K from 30 others
What the payments were for
- Speaking & faculty fees$8,20045%
- Travel & lodging$2,88516%
- Food & beverage$7,28440%
- Education$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Indivior Inc. | 25 | $11,643 |
| Amgen(2 entities) | 34 | $659 |
| AbbVie(2 entities) | 68 | $622 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 45 | $555 |
| Boehringer Ingelheim | 42 | $540 |
| GSK | 45 | $454 |
| AstraZeneca | 22 | $446 |
| Lilly USA, LLC | 38 | $432 |
| Grifols USA, LLC | 27 | $320 |
| Johnson & Johnson | 25 | $281 |
| Novo Nordisk | 24 | $271 |
| Pfizer | 25 | $258 |
| Astellas Pharma US Inc | 14 | $243 |
| Merck | 23 | $235 |
| Teva Pharmaceuticals USA, Inc. | 12 | $182 |
| Amarin Pharma, Inc. | 15 | $178 |
| Alkermes, Inc. | 7 | $111 |
| Gilead | 8 | $104 |
| Arbor Pharmaceuticals, Inc. | 6 | $100 |
| Avanir Pharmaceuticals, Inc. | 7 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $85 |
| Novartis | 5 | $68 |
| Esperion Therapeutics, Inc. | 4 | $64 |
| Daiichi Sankyo Inc. | 4 | $55 |
| Sunovion Pharmaceuticals Inc. | 4 | $49 |
| IBSA Pharma Inc. | 3 | $49 |
| Scilex Pharmaceuticals Inc. | 3 | $47 |
| Biohaven Pharmaceuticals, Inc. | 3 | $44 |
| Almatica Pharma LLC | 2 | $42 |
| Eisai Inc. | 3 | $41 |
| Paratek Pharmaceuticals, Inc. | 2 | $36 |
| Vifor Pharma, Inc. | 1 | $20 |
| Titan Pharmaceuticals, Inc. | 1 | $16 |
| Optinose US, Inc. | 1 | $14 |
| Radius Health, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,375 in reported general payments places this provider in the 95th percentile of 4,321 family medicine providers in New York.
Other family medicine in Liverpool
- Louis BonavitaEast Syracuse$674K
- Martin MahoneyBuffalo$520K
- Scott BrehautClinton$514K
- David St PeterSaratoga Springs$395K
- Matthew PabisNew York$222K
- Rajveer SachdevPomona$211K
- Eric SchnakenbergHalfmoon$190K
- James NorthGlens Falls$186K
- Eric BatesNew York$171K
- Alexander BlinskiNew York$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.